GENERIC SUB-STUDY SUBMISSION – 0925-0589-06
DATE OF REQUEST: November 29, 2010
SUB AGENCY (I/C): NIH/NCI/DCCPS
TITLE OF SUB-STUDY: Health Information National Trends Survey (HINTS) 4 Advance
Materials Focus Groups
GENERIC CLEARANCE UNDER OMB #0925-0589-06 EXP. DATE: 05/31/2011
TOTAL ANNUAL BURDEN APPROVED: 1800 hours
BURDEN APPROVED TO DATE: 1585 hours
BURDEN THIS REQUEST: 67 hours
The National Cancer Institute’s Division of Cancer Control and Population Sciences, Behavior Research Program is planning to conduct data collection for the Health Information National Trends Survey 4 (HINTS 4) over the course of three years starting in 2011. This submission is the first in a series of generic sub-studies designed to prepare HINTS 4 materials that will be used for data collection over a three-year period.
For this generic sub-study, NCI is proposing formative research to refine the mailing materials associated with a national mail-based survey. These materials include: the prenotification letter, the cover letter, and the reminder postcard. The goal of this formative research is to make the content and appearance of the mailing materials appealing to potential respondents in order to increase the likelihood that they would complete the survey (and to therefore increase response rates for the survey).
The research will consist of conducting 4 focus groups with people who meet the eligibility criteria for HINTS 4 (adult over 18 years of age and non-institutionalized resident of the United States). Each focus group will be with 8-10 people. Two of the focus groups will be in English and two will be conducted in Spanish with Spanish-speaking participants.
IS RACE AND ETHNICITY DATA COLLECTED AS REQUIRED?
___X___YES _____NO_______N/A
OBLIGATION TO RESPOND:
___X__ VOLUNTARY
______ REQUIRED TO OBTAIN OR RETAIN BENEFITS
______ MANDATORY
HOW WILL THIS SURVEY BE OFFERED?
_____ WEB SITE
_____ TELEPHONE INTERVIEW
_____ MAIL RESPONSE
__X___ IN PERSON INTERVIEW
_____ OTHER: __ _______________________
CONTACT INFORMATION:
NAME: Bradford Hesse
TELEPHONE NUMBER: 301-594-9904
EMAIL ADDRESS: [email protected]
GENERIC SUB-STUDY SUBMISSION – 0925-0589-07
DATE OF REQUEST: November 29, 2010
SUB AGENCY (I/C): NIH/NCI/DCCPS
TITLE OF SUB-STUDY: Cognitive Testing for Multidisciplinary Care Survey
GENERIC CLEARANCE UNDER OMB #0925-0589-07 EXP. DATE: 5/31/2011
TOTAL BURDEN APPROVED: 1800 hours
BURDEN APPROVED TO DATE: 1585 hours
BURDEN THIS REQUEST: 30 hours
With the growth of multi-modality cancer therapies, cancer specialists (surgeons, radiation oncologists and medical oncologists) need to communicate and coordinate treatment planning among themselves and with cancer patients more than ever. As a result, community cancer centers have been developing a wide variety of multidisciplinary care programs to facilitate improved coordinated cancer care and execution. Little is known about the variation in program structures, organizational processes and methods of engaging patients in these multidisciplinary care programs. The NCI’s Division of Cancer Control and Population Sciences research team will collaborate with the American College of Surgeons, Commission on Cancer (CoC) to develop and cognitively test questions on the Multidisciplinary Care (MDC) survey with the support of the contractor, Westat. Findings from the cognitive interviews will be used to improve any problems with questions prior to finalizing the MDC Survey for administration by the Commission on Cancer. Respondents for the cognitive interviews will be 18 physicians and administrators, mostly in hospital settings. The cognitive probes will focus primarily on item interpretation and ease of response. Interviewers will also ask a set of probes to get at respondents’ overall impressions of the instrument, as well as suggestions for improvement, such as rewording or changing the order in which questions are presented. Additional issues to be discussed may include: general willingness to participate, potential motivators for participating, and any issues seen as relevant from the multidisciplinary care provider’s perspective.
IS RACE AND ETHNICITY DATA COLLECTED AS REQUIRED?
______YES ___X__NO_______N/A
OBLIGATION TO RESPOND:
___X__ VOLUNTARY
______ REQUIRED TO OBTAIN OR RETAIN BENEFITS
______ MANDATORY
HOW WILL THIS SURVEY BE OFFERED?
_____ WEB SITE
___X__ TELEPHONE INTERVIEW
_____ MAIL RESPONSE
___X__ IN PERSON INTERVIEW
_____ OTHER: __ _______________________
CONTACT INFORMATION:
NAME: Irene Prabhu Das
TELEPHONE NUMBER: 301-451-5803
EMAIL ADDRESS: [email protected]
GENERIC SUB-STUDY SUBMISSION – 0925-0589-08
DATE OF REQUEST: November 29, 2010
SUB AGENCY (I/C): NIH/NCI/DCCPS
TITLE OF SUB-STUDY: Evaluation of the NCI Experimental Therapeutics (NExT) Website
GENERIC CLEARANCE UNDER OMB #0925-0589-08 EXP. DATE: 5/31/2011
TOTAL BURDEN APPROVED: 1800 hours
BURDEN APPROVED TO DATE: 1585 hours
BURDEN THIS REQUEST: 32 hours
The National Cancer Institute (NCI) launched the NCI Experimental Therapeutics (NExT) Program in 2009 to accelerate cancer treatments from the lab to the clinic. The program is collaboration between the NCI Division of Cancer Treatment and Diagnosis (DCTD) and the Center for Cancer Research. NExT consolidates NCI’s anticancer drug discovery and development resources into a robust, balanced, goal-driven therapeutics pipeline of high-priority projects. The NExT website (http://next.cancer.gov/) serves to educate scientists in government, academia, and industry about the NExT program and how they may participate in it. NExT provides support to researchers whose proposals are assessed for scientific merit by a review committee. Most importantly, the website also contains an electronic application to the NExT program.
This evaluation is intended to determine the effectiveness and usability of the NExT website to ensure that potential participants can find the information they need to understand and apply for the NExT Program and to determine if current NExT participants can find the information they need to proceed with the steps of the NExT Program. Anticipated recruitment will include three basic categories: people already familiar with NExT (“experts”), people who know a little about NExT (“novices”), and those who are totally unfamiliar with the program. The types of respondents will include Principle Investigators (PI) who work as academics, members of industry, representatives of the pharmaceutical industry, and government researchers.
IS RACE AND ETHNICITY DATA COLLECTED AS REQUIRED?
______YES ___X__NO_______N/A
OBLIGATION TO RESPOND:
___X__ VOLUNTARY
______ REQUIRED TO OBTAIN OR RETAIN BENEFITS
______ MANDATORY
HOW WILL THIS SURVEY BE OFFERED?
_____ WEB SITE
___X__ TELEPHONE INTERVIEW
_____ MAIL RESPONSE
___X__ IN PERSON INTERVIEW
_____ OTHER: _________________________
CONTACT INFORMATION:
NAME: Lynn Cave
TELEPHONE NUMBER: 301-402-0912
EMAIL ADDRESS: [email protected]
| File Type | application/msword |
| File Title | SUBMISSION OF INFORMATION COLLECTION |
| Author | Nina Goodman, MHS |
| Last Modified By | Vivian Horovitch-Kelley |
| File Modified | 2010-11-29 |
| File Created | 2010-11-29 |